Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Lymphoid 4Other hematologic neoplasm 3Sarcoma 2Gynecologic 2Genitourinary 2Plasma cell 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Anemia, Refractory, with Excess of Blasts 18Leukemia 17Myelodysplastic Syndromes 16Leukemia, Myelomonocytic, Chronic 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Myeloid, Acute 11Congenital Abnormalities 10Myeloproliferative Disorders 8Blast Crisis 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma 7Leukemia, Myeloid, Accelerated Phase 7Anemia, Refractory 7Primary Myelofibrosis 6Lymphoma, Non-Hodgkin 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Lymphocytic, Chronic, B-Cell 6Polycythemia Vera 5Multiple Myeloma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Burkitt Lymphoma 5Thrombocytopenia 4Thrombocythemia, Essential 4Neoplasms, Plasma Cell 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4

Interventions

pegfilgrastim 2Epoetin Alfa 2Cisplatin 2sodium thiosulfate 1etoposide phosphate 1Rituximab 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Erythropoietin 1Docetaxel 1Darbepoetin alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Brachytherapy 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Etoposide × Classical hematology × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡